Ebola Vaccine Candidates: Phase 1 Trial Results (NEJM)

The following two tabs change content below.
Kenny Pettersen

Kenny Pettersen

Kenny Pettersen holds a Master of Public Health and is currently finishing medical school at UC San Francisco. He has worked extensively in Haiti since 2004 and among homeless populations in the US. He is particularly interested in improving chronic disease management through health systems strengthening efforts, such as eHealth and health workforce development.

This week, preliminary results from two phase 1 trials were published in the New England Journal of Medicine.

Overall, the trials demonstrated safety and the ability to generate expected immune response. Subsequent trials will aim to demonstrate efficacy in preventing infection with Ebola Virus Disease in West Africa.

To review the results, view the trails at the links below:

Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe — Preliminary Report

A Recombinant Vesicular Stomatitis Virus Ebola Vaccine — Preliminary Report